GarciaJHendel-ChavezHDe-GoerM-G, et al. Progressive multifocal leukoencephalopathy on dimethyl fumarate with preserved lymphocyte count but deep T-cells exhaustion. Mult Scler J2021; 27(4): 640–645.
2.
GheuensSBordEKesariS, et al. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol2011; 85(14): 7256–7263.
3.
TanCSBordEBrogeTA, et al. Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy. J Acquir Immune Defic Syndr2012; 60(3): 244–248.
4.
BergerJRPallLLanskaD, et al. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol1998; 4(1): 59–68.
5.
CorteseIMuranskiPEnose-AkahataY, et al. Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med2019; 380(17): 1597–1605.
